- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-mer
- Ligands
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 5 x PEV: (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE(Non-covalent)
PEV.3: 10 residues within 4Å:- Chain A: D.952, F.953, G.954, F.997, K.998, R.1004, V.1007, R.1008, F.1011, L.1345
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:F.953, A:F.953, A:F.997, A:F.1011, A:F.1011, A:F.1011, A:L.1345
- Salt bridges: A:R.1008
PEV.4: 11 residues within 4Å:- Chain A: L.1025, G.1102, L.1106, F.1109, Y.1420, A.1421, M.1425, C.1428, S.1429, V.1432
- Ligands: PEV.7
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:L.1025, A:L.1106, A:F.1109, A:Y.1420, A:V.1432
PEV.5: 8 residues within 4Å:- Chain A: L.881, L.884, I.897, V.1000, Q.1002, Y.1333, F.1336, F.1337
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:I.897, A:V.1000, A:Y.1333, A:F.1336, A:F.1336, A:F.1337
- Hydrogen bonds: A:Q.1002
PEV.6: 14 residues within 4Å:- Chain A: Y.192, L.195, Q.198, M.199, W.296, R.297, F.300, F.308, K.1230, M.1301, A.1304, C.1305, V.1308, F.1312
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:W.296, A:W.296, A:F.300, A:F.308, A:V.1308, A:F.1312
- Hydrogen bonds: A:C.1305
- Salt bridges: A:R.297, A:R.297
PEV.7: 7 residues within 4Å:- Chain A: I.399, S.403, Y.405, N.1100, V.1101
- Chain B: Y.365
- Ligands: PEV.4
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:I.399
- Hydrogen bonds: A:N.1100, A:V.1101, A:G.1102, B:Y.365
- 2 x PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE(Non-covalent)
PGV.8: 15 residues within 4Å:- Chain A: E.979, S.980, G.981, Q.983, L.984, L.991, L.1345, Y.1349, A.1352, L.1356, N.1419, G.1422, M.1425, Y.1426
- Ligands: Y01.11
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:L.984, A:L.1345, A:Y.1349, A:A.1352, A:L.1356, A:M.1425, A:Y.1426
- Hydrogen bonds: A:E.979, A:G.981, A:N.1419
PGV.9: 16 residues within 4Å:- Chain A: V.510, T.513, A.514, L.517, P.541, R.542, F.544, M.545, I.1125, P.1130, G.1133, I.1134, H.1137, V.1138, F.1141
- Ligands: Y01.10
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:V.510, A:T.513, A:A.514, A:L.517, A:F.544, A:P.1130, A:I.1134, A:V.1138, A:F.1141, A:F.1141, A:F.1141
- Salt bridges: A:R.542, A:R.542
- 3 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.10: 9 residues within 4Å:- Chain A: I.51, C.54, T.60, H.63, Y.64, T.539, F.540, P.541
- Ligands: PGV.9
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:I.51, A:Y.64, A:T.539, A:F.540, A:F.540
- Salt bridges: A:H.63, A:R.542
Y01.11: 7 residues within 4Å:- Chain A: F.960, L.963, I.967, W.971, G.981, L.985
- Ligands: PGV.8
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:F.960, A:L.963, A:I.967, A:W.971, A:L.985
Y01.12: 3 residues within 4Å:- Chain A: P.916, Y.923, I.927
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:Y.923, A:I.927
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kschonsak, M. et al., Structure of the human sodium leak channel NALCN. Nature (2020)
- Release Date
- 2020-07-29
- Peptides
- Sodium leak channel non-selective protein: A
Transmembrane protein FAM155A: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-mer
- Ligands
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 5 x PEV: (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE(Non-covalent)
- 2 x PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE(Non-covalent)
- 3 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kschonsak, M. et al., Structure of the human sodium leak channel NALCN. Nature (2020)
- Release Date
- 2020-07-29
- Peptides
- Sodium leak channel non-selective protein: A
Transmembrane protein FAM155A: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.